> ## Content Index
> Fetch the complete content index at: https://members.americanhealthintel.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Genentech pays up to $2.3B for Hanmi's unproven obesity drug
- URL: https://members.americanhealthintel.com/2026-08-24-ledger/
- Published: 2026-08-24T16:01:47.000Z
- Updated: 2026-08-24T16:01:47.000Z
- Description: Plus: Bon Secours buys Fauquier Health from Apollo-backed LifePoint. The day's rules, money, and enforcement, sourced and tiered below.
- Author: American Health Intel

Plus: Bon Secours buys Fauquier Health from Apollo-backed LifePoint. The day's rules, money, and enforcement, sourced and tiered below.

| American Health Intel Rules · Money · Medicine · Decoded daily The Ledger Monday, August 24, 2026 Genentech pays up to $2.3B for Hanmi's unproven obesity drug Plus: Bon Secours buys Fauquier Health from Apollo-backed LifePoint. The day's rules, money, and enforcement, sourced and tiered below. ![](https://americanhealthintel.com/email/pulse-divider.png) Deal Confidence: High Genentech, the Roche-owned drugmaker behind cancer and immunology blockbusters, is paying up to $2.3 billion for an unproven obesity pill from Korea's Hanmi Pharmaceutical, betting it avoids GLP-1's muscle-loss problem. Hanmi gets $190 million upfront now, with the rest tied to milestones. The drug, HM17321, targets a different biological pathway than Ozempic or Wegovy and is designed to preserve lean muscle while patients lose fat. Why it matters This is a record-setting bet on an obesity drug candidate that has not started Phase 2 testing; watch whether it can actually avoid the muscle-loss side effect drawing scrutiny to current GLP-1 drugs. Sources: [Prnewswire](https://www.prnewswire.com/news-releases/hanmi-pharm-signs-exclusive-licensing-deal-with-genentech-for-novel-obesity-therapy-302858053.html?ref=members.americanhealthintel.com) Deal Confidence: High Bon Secours Mercy Health, a large Catholic nonprofit hospital system, is buying Fauquier Health, a 97-bed Virginia hospital, from LifePoint Health, the for-profit chain majority owned by Apollo Global Management. It's Bon Secours Mercy Health's 48th hospital, its fifth state. The deal, expected to close this fall, converts the hospital from for-profit to nonprofit; neither side disclosed a price. Why it matters This is another example of a financially stretched or non-core hospital moving from a private equity-backed chain to a larger nonprofit system; watch how the conversion affects local services and pricing. Sources: [Beckershospitalreview](https://www.beckershospitalreview.com/hospital-transactions-and-valuation/bon-secours-mercy-health-to-acquire-48th-hospital/?ref=members.americanhealthintel.com) · [Fauquiernow](https://www.fauquiernow.com/news/fauquier-health-to-join-bon-secours-mercy-health-network-in-acquisition-44e2bb17?ref=members.americanhealthintel.com) Also today Mount Carmel permanently closes Columbus ED [Read](https://americanhealthintel.com/editions/2026-08-24-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#mount-carmel-franklinton-ed-closure) Utah medical distributor files Chapter 11, wipes out creditors [Read](https://americanhealthintel.com/editions/2026-08-24-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#premier-medical-distribution-chapter11) Dubai wellness company SuperiorMed to go public via SPAC [Read](https://americanhealthintel.com/editions/2026-08-24-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#superiormed-starry-sea-spac-merger) 576Records$34.3BEnforcement27Deadlines158Rules [Read this issue + the trackers](https://americanhealthintel.com/editions/2026-08-24-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) Pick your field on the site and every story tells you what it means for you. Reply to this email and tell us what you want covered. We read everything. We show our work. We score our own calls. [Track record](https://americanhealthintel.com/ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Calendar](https://americanhealthintel.com/calendar/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Enforcement](https://americanhealthintel.com/enforcement/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [X](https://x.com/amhealthintel?ref=members.americanhealthintel.com) · [LinkedIn](https://www.linkedin.com/company/american-health-intel?ref=members.americanhealthintel.com) News and analysis, not legal, medical, coding, or investment advice.You subscribed at americanhealthintel.com · [Unsubscribe](%%{unsubscribe%5Furl}%%) |
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |